Vivek Ramaswamy

**Vivek Ganapathy Ramaswamy**  (an haife shi a watan Agusta 9, 1985) ɗan kasuwan Amurka ne kuma ɗan siyasa. Ya kafa Roivant Sciences, wani kamfanin harhada magunguna, a cikin 2014. A watan Fabrairun 2023, Ramaswamy ya ayyana takarar sa na jam'iyyar Republican a zaben shugaban kasa na Amurka na 2024. Ya dakatar da yakin neman zabensa ne a watan Janairun 2024, bayan ya kammala na hudu a jam'iyyar Iowa, kuma ya ci gaba da amincewa da takarar Trump.

An haifi Ramaswamy a Cincinnati ga iyayen baƙi Indiya. Ya kammala karatunsa na farko a Jami'ar Harvard da digirin farko a fannin ilmin halitta, sannan ya sami digiri a Makarantar Yale Law School. Ramaswamy ya yi aiki a matsayin abokin zuba jari a asusun shinge kafin ya kafa Roivant Sciences. Ya kuma kafa kamfanin zuba jari mai suna Strive Asset Management. Ramaswamy ya bayyana cewa yana ganin Amurka a tsakiyar rikicin asalin kasa da abin da ya kira "sababbin addinan duniya kamar COVID-ism, yanayin yanayi, da akidar jinsi". Har ila yau, mai sukar manufofin muhalli, zamantakewa, da kamfanoni ne. A cikin Janairu 2024, Forbes ta kiyasta darajar Ramaswamy fiye da dala miliyan 960; dukiyarsa ta fito ne daga fasahar kere-kere da kasuwancin kudi.

## Rayuwar farko da ilimi
An haife shi a ranar 9 ga Agusta, 1985, a Cincinnati, Ohio, ga iyayen ƙaura na Indiyawan Indiya. Iyayensa Tamil Brahmins ne daga Kerala.Mahaifinsa, V. Ganapathy Ramaswamy, wanda ya kammala karatun digiri na Cibiyar Fasaha ta Kasa ta Calicut, ya yi aiki a matsayin injiniya na Janar Electric, yayin da mahaifiyarsa, Geetha Ramaswamy, wanda ya kammala digiri na Kwalejin Kiwon Lafiya ta Mysore & Cibiyar Bincike, ya yi aiki a matsayin likitan ilimin likitanci na Merck da Schering-Plough. Iyayensa sun yi ƙaura daga gundumar Palakkad a cikin Kerala, inda dangi ke da gidan kakanni a cikin al'adun gargajiya na al'ada a cikin garin Vadakkencherry.

Ramaswamy ya girma an Ohio.Lokacin girma, Ramaswamy yakan halarci haikalin Hindu na gida a Dayton tare da danginsa. Malamin piano na Kirista mai ra'ayin mazan jiya, wanda ya ba shi darussa na sirri tun daga firamare har zuwa sakandare, shi ma ya rinjayi ra'ayinsa na zamantakewa. Ya yi hutun bazara da yawa yana tafiya Indiya tare da iyayensa.A makarantar sakandare, Ramaswamy ya kasance ɗan wasan tennis mai matsayi na ƙasa.

## Ilimi
Ramaswamy ya halarci makarantun gwamnati har zuwa aji takwas. Daga nan ya halarci makarantar sakandare ta Cincinnati ta St. Xavier, makarantar Katolika da ke da alaƙa da tsarin Jesuit, wanda ya kammala karatun digiri a matsayin valedictorian a 2003. A cikin 2007, Ramaswamy ya sauke karatu daga Jami'ar Harvard tare da Bachelor of Arts, summa cum laude, a fannin ilmin halitta, kuma ya kasance memba na Phi Beta Kappa.A Harvard, ya sami suna a matsayin jajirtacce kuma mai kwarin gwiwa.Ya kasance memba na Ƙungiyar Siyasa ta Harvard, ya zama shugabanta.Ya gaya wa The Harvard Crimson cewa ya ɗauki kansa a matsayin mai saɓani mai son yin muhawara[26]. Yayin da yake kwaleji, ya yi suturar Eminem da kiɗan rap na 'yanci a ƙarƙashin sunan mataki da canjin kuɗi "Da Vek", kuma ya kasance ƙwararren mai ba da shawara ga asusun shinge na Amaranth Advisors da bankin saka hannun jari Goldman Sachs. Ya rubuta babban littafinsa akan tambayoyin da'a da aka taso ta hanyar ƙirƙirar chimeras na ɗan adam, wanda ya ba shi lambar yabo ta Bowdoin.

A cikin 2011, Paul & Daisy Soros Fellowships don Sabbin Ba'amurke sun ba Ramaswamy haɗin gwiwa na gaba da digiri.Daga baya Ramaswamy ya ce a lokacin da ya halarci Yale, ya riga ya kasance mai arziki daga ayyukansa a masana'antar hada-hadar kudi, magunguna, da fasahar kere-kere; ya ce a shekarar 2023 yana da dukiyar da ta kai kusan dala miliyan 15 kafin ya kammala karatunsa a makarantar lauya.A Yale, ya yi abota da ɗan'uwan ɗan ƙasar Ohio kuma mataimakin shugaban Amurka JD Vance na gaba.Ya sami Likitan Juris a shekara ta 2013. A cikin wata hira ta 2023, Ramaswamy ya ce shi mamba ne na harabar kungiyar Tattaunawa ta Yahudanci Shabtai yayin da yake karatun shari'a.

## Sana'ar kasuwanci
### Aikin farko
A cikin 2007, Ramaswamy da Travis May sun kafa cibiyar sadarwa ta Campus Venture Network, wacce ta buga gidan yanar gizon sadarwar zamantakewa mai zaman kansa don ɗaliban jami'a waɗanda ke da burin ƙaddamar da kasuwanci. An sayar da kamfanin ga gidauniyar Ewing Marion Kauffman mai zaman kanta a cikin 2009. Ramaswamy ya yi aiki a asusun shinge na QVT Financial daga 2007 zuwa 2014. Ya kasance abokin tarayya kuma yana gudanar da haɗin gwiwar babban fayil ɗin fasahar kere kere na kamfanin.Zuba jarin fasahar kere kere ta QVT a ƙarƙashin Ramaswamy ya haɗa da hannun jari a cikin Fasahar Palatin,  Concert Pharmaceuticals, Pharmasset, da Martin Shkreli's Retrophin. A cikin jawabin 2023 da kuma a cikin littafinsa Woke Inc., Ramaswamy ya kira Shkreli, wanda kamfaninsa ya haɓaka farashin magani mai ceton rai, duka "mai haske" da maƙaryaci. Ya soki 
ma'aikatar shari'a ta Amurka da laifin gurfanar da Shkreli, yana mai cewa zamba da ya yi laifi ne marar laifi.

## Roivant Sciences da rassa
A cikin 2014, Ramaswamy ya kafa kamfanin Roivant Sciences na kimiyyar halittu; "Roi" a cikin sunan kamfani yana nufin komawa kan zuba jari. An haɗa kamfanin a Bermuda, wurin ajiyar haraji, kuma ya karɓi kusan dala miliyan 100 a cikin babban birnin farawa daga QVT da sauran masu saka hannun jari,  ciki har da RA Capital Management, Visium Asset Management, da masu kula da asusun shinge D. E. Shaw & Co. da Falcon Edge Capital.Dabarar Roivant ita ce siyan haƙƙin mallaka daga manyan kamfanonin harhada magunguna na magungunan da ba a yi nasarar samar da su ba, sannan a kawo su kasuwa. Kamfanin ya ƙirƙira rassan da yawa,ciki har da Dermavant (ya mai da hankali kan ilimin fata), Urovant (ya mai da hankali 
kan cutar urological), da Sinovant da Cytovant na tushen China, duka sun mai da hankali kan kasuwar Asiya.

A cikin 2015, Ramaswamy ya tara dala miliyan 360 don Roivant na Axovant Sciences a yunƙurin tallata intepirdine a matsayin magani don cutar Alzheimer. A cikin Disamba 2014,  Axovant ya sayi patent don intepirdine daga GlaxoSmithKline (inda maganin ya gaza gwajin gwaji huɗu na asibiti) akan dala miliyan 5, ƙaramin kuɗi a cikin masana'antar. Ramaswamy ya bayyana a bangon Forbes a cikin 2015, kuma ya ce kamfaninsa zai zama "mafi girman komawa kan kokarin saka hannun jari da aka taba samu a masana'antar harhada magunguna." Da farko darajar kasuwar ta haura zuwa kusan dala biliyan 3, duk da cewa a lokacin yana da ma'aikata takwas ne da suka hada da kanin Ramaswamy da mahaifiyarsa. Ramaswamy ya ci riba mai yawa bayan ya sayar da wani kaso na hannun jarinsa a Roivant ga Viking Global Investors.Ya yi ikirarin sama da dala miliyan 37 a cikin babban jari a shekarar 2015. Ramaswamy ya ce kamfaninsa zai zama "Berkshire Hathaway na ci gaban magunguna" kuma ya yi la'akari da maganin a matsayin "babban dama" wanda "zai iya taimakawa miliyoyin" marasa lafiya, wanda ya haifar da sukar da ya yi.

A cikin Satumba 2017, kamfanin ya sanar da cewa intepidine ya gaza a cikin babban gwaji na asibiti.Darajar kamfanin ta yi kasa; ya yi asarar kashi 75 cikin 100 a rana guda kuma ya ci gaba da raguwa daga baya. Masu hannun jarin da suka yi asarar kuɗi sun haɗa da masu saka hannun jari daban-daban, kamar asusun fansho na tsarin fansho na Malamai na Jihar California.An kebe Ramaswamy daga yawancin asarar Axovant saboda ya rike hannun jarinsa ta hanyar Roivant.Kamfanin ya watsar da intepirdine. A cikin 2018, Ramaswamy ya ce bai yi nadama ba game da yadda kamfanin ke sarrafa maganin;a cikin shekaru masu zuwa, ya ce ya yi nadamar sakamakon amma ya ji haushin sukar kamfanin.Bayan haka Axovant yayi ƙoƙarin sake ƙirƙira kanta a matsayin kamfanin sarrafa kwayoyin halitta, [46] kuma ya narkar da shi a cikin 2023.

A cikin 2017, Roivant ya yi haɗin gwiwa tare da CITIC Private Equity na rukunin CITIC mallakar gwamnatin kasar Sin don kafa Sinovant. A cikin 2017, Ramaswamy ya kulla yarjejeniya da Masayoshi Son inda SoftBank ya zuba jarin dala biliyan 1.1 a Roivant.A cikin 2019, Roivant ya sayar da hannun jarinsa a cikin rassan biyar (ko "vants"), gami da Enzyvant, zuwa Sumitomo Dainippon Pharma; Ramaswamy ya sami dala miliyan 175 a cikin babban riba daga siyarwar.Yarjejeniyar ta kuma baiwa Sumitomo Dainippon hannun jari na 10% na Roivant.A lokacin da yake yakin neman zaben shugaban kasa, Ramaswamy ya kira kansa “masanin kimiyya” ya ce, “Na kirkiro magunguna da dama”. A cikin Janairu 2021, Ramaswamy ya sauka a matsayin Shugaba na Roivant Sciences kuma ya ɗauki matsayin shugaban zartarwa.A cikin 2021, bayan ya yi murabus a matsayin Shugaba, an jera Roivant akan Nasdaq ta hanyar haɗin kai tare da Montes Archimedes Acquisition Corp, abin hawa na musamman na siye. A cikin Fabrairu 2023, Ramaswamy ya sauka a matsayin shugaban Roivant don mai da hankali kan yakin neman zabensa.Ramaswamy ya kasance mai hannun jari na shida mafi girma na Roivant,yana riƙe da kashi 7.17%.A lokacin Ramaswamy yana tafiyar da Roivant kamfanin bai taɓa samun riba ba.

### Roivant Social Ventures
A cikin 2020, lokacin da Ramaswamy ya kasance Shugaba na Roivant Sciences, kamfanin ya kafa wata ƙungiya mai tasiri ta zamantakewa, Roivant Social Ventures (RSV), tare da goyon bayansa.An kirkiro RSV a baya, Roivant Foundation, a cikin 2018. Kodayake yakin neman zaben shugaban kasa na Ramaswamy ya dogara ne akan adawa da bambancin kamfanoni, daidaito, da haɗawa (DEI) da manufofin muhalli, zamantakewa, da tsarin gudanarwa (ESG), RSV ya yi aiki don tallafawa shirye-shiryen pro-DEI da ESG, gami da haɓaka daidaiton lafiya da bambancin a cikin masana'antar biopharma da fasahar kere kere. Yayin yakin neman zabe, Ramaswamy ya rage rawar da yake takawa wajen kirkirowa da kuma kula da RSV

### Ƙarfafa Gudanar da Dukiya
A farkon 2022, tare da abokinsa na makarantar sakandare Anson Frericks, ramsawa ya kafa Strive Asset Management, wani kamfanin sarrafa kadari na tushen Columbus, Ohi. Kamfanin ya tara kusan dala miliyan 20 daga masu saka hannun jari na waje, ciki har da Peter Thiel, JD Vance, da Bill Ackman.Strive ya sanya kansa a matsayin "anti-woke" da kudadensa a matsayin "anti-ESG"; Ramaswamy ya yi iƙirarin cewa manyan manajojin kadara, irin su BlackRock, Titin Jiha, da Vanguard, suna haɗa kasuwanci tare da siyasar ESG don cutar da masu saka hannun jarin su.Manajojin asusun fansho suna yin la'akari da ESG a cikin kimanta haɗarin haɗari na dogon lokaci, gami da haɗarin yanayi, lokacin yin yanke shawara na fayil.Ramaswamy ya yi yaƙi da ESG kuma ya jaddada koyarwar fifikon masu hannun jari, sanannen sanannen Milton Friedman.A cikin littafinsa Woke, Inc.: Ciki da Scam na Adalci na Jama'a na Amurka da sauran wurare, ya kwatanta saka hannun jari na kamfanoni masu zaman kansu a matsayin rashin tasiri a lokaci guda kuma babbar barazana ga al'ummar Amurka. Ya buga littafi na biyu, Nation of Victims: Identity Politics, Death of Merit, and the Path Back to Excellence, a cikin Satumba 2022, 'yan watanni kafin ya bayyana takararsa ta shugaban kasa.

Strive's flagship asusu, asusun musayar musayar DRLL, wanda aka ƙaddamar a cikin 2022 a matsayin asusun index na ɓangaren makamashi na "anti-wake". Ramaswamy ya ce Strive zai tura kamfanonin samar da makamashi don hako mai, da samar da iskar gas, da yin duk abin da zai ba su damar samun nasara a cikin dogon lokaci ba tare da la'akari da manufofin siyasa, zamantakewa, al'adu ko muhalli ba. A cikin Oktoba 2022, Ramaswamy ya yi ganawar sirri tare da 'yan majalisar South Carolina a wani zama da ma'ajin jihar Curtis Loftis ya shirya; a lokacin tarurruka, Ramaswamy ya kafa Ƙoƙari don sarrafa kuɗaɗen fensho na South Carolina. A cikin watan Yuni 2023, bayan The Post da Courier sun ba da rahoto game da tarurrukan, an soki zaman a matsayin wani nau'i na shiga tsakani da ba a yi rajista ba; Manajan yakin neman zaben Ramaswamy ya musanta aikata wani laifi. Ramaswamy shine shugaban zartarwa na Strive kafin yayi murabus a watan Fabrairu 2023 don mai da hankali kan yakin neman zabensa na shugaban kasa.

## Sauran harkokin kasuwanci
A cikin 2020, Ramaswamy ya kafa Babi na Medicare, dandamalin kewayawa na Medicare.[68] Ya yi aiki a cikin Tawagar Amsa COVID-19 na Ohio.Ya kasance shugaban OnCore Biopharma, matsayin da ya rike a Tekmira Pharmaceuticals lokacin da kamfanonin biyu suka hade a cikin Maris 2015. Ya kuma kasance shugaban kwamitin Arbutus Biopharma, wani kamfani na Kanada.[34] A cikin Mayu 2024, Ramaswamy ya sami hannun jari na 7.7% a BuzzFeed, daga baya ya karu zuwa 8.4%, wanda ya sanya shi zama na biyu mafi girma na Class A a cikin kamfanin.Ba da daɗewa ba bayan sayan, sai ya aika da wasiƙa zuwa ga kwamitin gudanarwa na kamfanin, inda ya ba da shawarar su ɗauki ƙwararrun masana masu ra'ayin mazan jiya irin su Candace Owens, Tucker Carlson, da Bill Maher, da kuma "manyan daraktoci guda uku, tare da bayanan kasuwanci masu ƙarfi a cikin sababbin kafofin watsa labaru" waɗanda ya sani.Manazarta sun yi hasashen cewa jagorar sa na iya canza abubuwan da BuzzFeed ke ciki da tsarin edita da gaske.

## Rayuwar sirr
Matar Ramaswamy, Apoorva Tewari Ramaswamy, likitan laryngologist ne kuma likitan fiɗa; sun hadu a Yale, lokacin yana karatun shari'a kuma tana karatun likitanci. Sun yi aure a shekara ta 2015 kuma sun haifi 'ya'ya maza biyu. Ramaswamy yana da ƙane, Shankar,wanda ya yi masa aiki a Axovant kuma daga baya ya kafa Kriya Therapeutics, wani kamfani na biopharmaceutical. Ramaswamy Hindu ce mai tauhidi. A cewar dangi, yana iya magana da Tamil kuma yana fahimtar (amma baya magana) Malayalam. Shi mai cin ganyayyaki ne kuma ya rubuta a cikin 2020 cewa, "Na yi imani ba daidai ba ne a kashe dabbobi masu jin dadi don jin daɗin abinci." A cikin 2023, mai ba wa Ramaswamy shawara kan yakin neman zabe ya ce dukiyarsa ta haura dala biliyan 1;Forbes ta kiyasta fiye da dala miliyan 950. Ya zauna a Manhattan tun daga 2016. Tun daga 2021, ya mallaki gida a cikin gundumar Butler, Ohio,amma a cikin 2023, kadarorin da ya ba da rahoton mallakar shi ne gida a Columbus, Ohio, a cikin gundumar Franklin. Bayanan Siyasa na 2023 na Ramaswamy ya ambace shi yana zaune a cikin wani gida na dala miliyan 2 a unguwar Columbus na Upper Arlington.

## Manazarta